These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 30405615)
41. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression. Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473 [TBL] [Abstract][Full Text] [Related]
42. High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum. LaFranco-Scheuch L; Abel K; Makori N; Rothaeusler K; Miller CJ J Virol; 2004 Jun; 78(12):6399-408. PubMed ID: 15163733 [TBL] [Abstract][Full Text] [Related]
43. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251. Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249 [TBL] [Abstract][Full Text] [Related]
44. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230 [TBL] [Abstract][Full Text] [Related]
45. Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or interferon-gamma. Stahl-Hennig C; Gundlach BR; Dittmer U; ten Haaft P; Heeney J; Zou W; Emilie D; Sopper S; Uberla K Virology; 2003 Jan; 305(2):473-85. PubMed ID: 12573592 [TBL] [Abstract][Full Text] [Related]
46. [Protective immune responses against HIV/SIV by live attenuated vaccine in non-human primate models]. Fukazawa Y Uirusu; 2012; 62(2):167-74. PubMed ID: 24153227 [TBL] [Abstract][Full Text] [Related]
47. HIV vaccine research and discovery in the nonhuman primates model: a unified theory in acquisition prevention and control of SIV infection. Lynch RM; Yamamoto T; McDermott AB Curr Opin HIV AIDS; 2013 Jul; 8(4):288-94. PubMed ID: 23666390 [TBL] [Abstract][Full Text] [Related]
48. HIV vaccine development: lessons from the past and promise for the future. Spearman P Curr HIV Res; 2003 Jan; 1(1):101-20. PubMed ID: 15043215 [TBL] [Abstract][Full Text] [Related]
49. Nonhuman primate models for HIV/AIDS vaccine development. Sui Y; Gordon S; Franchini G; Berzofsky JA Curr Protoc Immunol; 2013 Oct; 102():12.14.1-12.14.30. PubMed ID: 24510515 [TBL] [Abstract][Full Text] [Related]
56. Current advances in HIV vaccine preclinical studies using Macaque models. Liang B; Li H; Li L; Omange RW; Hai Y; Luo M Vaccine; 2019 Jun; 37(26):3388-3399. PubMed ID: 31088747 [TBL] [Abstract][Full Text] [Related]
57. PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8 Rahman SA; Yagnik B; Bally AP; Morrow KN; Wang S; Vanderford TH; Freeman GJ; Ahmed R; Amara RR Sci Immunol; 2021 Sep; 6(63):eabh3034. PubMed ID: 34516743 [TBL] [Abstract][Full Text] [Related]
58. Preclinical AIDS vaccine development: formal survey of global HIV, SIV, and SHIV in vivo challenge studies in vaccinated nonhuman primates. Warren JT; Levinson MA J Med Primatol; 1997; 26(1-2):63-81. PubMed ID: 9271191 [No Abstract] [Full Text] [Related]
59. Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV. Ackerman ME; Das J; Pittala S; Broge T; Linde C; Suscovich TJ; Brown EP; Bradley T; Natarajan H; Lin S; Sassic JK; O'Keefe S; Mehta N; Goodman D; Sips M; Weiner JA; Tomaras GD; Haynes BF; Lauffenburger DA; Bailey-Kellogg C; Roederer M; Alter G Nat Med; 2018 Oct; 24(10):1590-1598. PubMed ID: 30177821 [TBL] [Abstract][Full Text] [Related]
60. Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab). Gill AL; Green SA; Abdullah S; Le Saout C; Pittaluga S; Chen H; Turnier R; Lifson J; Godin S; Qin J; Sneller MC; Cuillerot JM; Sabzevari H; Lane HC; Catalfamo M AIDS; 2016 Oct; 30(16):2487-2493. PubMed ID: 27490642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]